• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Shock . Extracorporeal Life Support (ECLS): A Review and Focus on Considerations for COVID-19

tetano

Editor, Senior Moderator
Shock


. 2020 Oct 8.
doi: 10.1097/SHK.0000000000001677. Online ahead of print.
Extracorporeal Life Support (ECLS): A Review and Focus on Considerations for COVID-19


Ali Tabatabai[SUP] 1 [/SUP], Samuel M Galvagno Jr, James V O'Connor, Thomas M Scalea, Kristopher B Deatrick



Affiliations

Abstract

Extracorporeal life support (ECLS) is a support modality for patients with severe acute respiratory distress syndrome (ARDS) who have failed conventional treatments including low tidal volume ventilation, prone positioning, and neuromuscular blockade. In addition, ECLS can be used for hemodynamic support for patients with cardiogenic shock or following cardiac arrest. Injured patients may also require ECLS support for ARDS and other indications. We review the use of ECLS for ARDS patients, trauma patients, cardiogenic shock patients, and post cardiac arrest patients. We then describe how these principles are applied in the management of the novel coronavirus disease (COVID-19) pandemic. Indications, predictors, procedural considerations, and post-cannulation management strategies are discussed.
 
Back
Top Bottom